drugset / Trial / NCT04646889
Pharmacokinetic Study of AR882 in Subjects With Various Degrees of Renal Impairment
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is a 2-segment, multi-center, phase 1, open-label, study evaluating the pharmacokinetics and pharmacodynamics of AR882 in subjects with various degrees of renal impairment.
Timeline
- Start
- 2021-01-14
- Primary completion
- 2022-06-27
- Completion
- 2022-06-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AR882 | Unknown | — | — |